Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Adrenocortical Carcinoma × TKM-080301 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Lymphoid 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Hodgkin Disease 1 Carcinoma, Hepatocellular 1 Carcinoid Tumor 1 Adrenocortical Carcinoma 1

Interventions

iodophenyl metomidate 1 TKM-080301 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01262235 2019-01-16

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Arbutus Biopharma Corporation

Phase 1/2 Completed

EndocrineLymphoidNET

Carcinoid Tumor, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡